Sensitivity to vaccines, therapeutic antibodies, and viral entry inhibitors and advances to counter the SARS-CoV-2 Omicron variant

H Zhou, M Møhlenberg, JC Thakor… - Clinical microbiology …, 2022 - journals.asm.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) keeps evolving and
mutating into newer variants over time, which gain higher transmissibility, disease severity …

Therapeutic monoclonal antibodies for COVID-19 management: an update

VP Chavda, R Prajapati, D Lathigara… - Expert opinion on …, 2022 - Taylor & Francis
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
affected more than 529 million people, and today the world is facing different mutant strains …

[HTML][HTML] Immune escape associated with RBD Omicron mutations and SARS-CoV-2 evolution dynamics

AV Kudriavtsev, AV Vakhrusheva, VN Novoseletsky… - Viruses, 2022 - mdpi.com
The evolution and the emergence of new mutations of viruses affect their transmissibility
and/or pathogenicity features, depending on different evolutionary scenarios of virus …

Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention

A Xu, B Hong, F Lou, S Wang, W Li, A Shafqat… - MedComm, 2022 - Wiley Online Library
Since the start of the coronavirus disease 2019 (COVID‐19) pandemic, new variants of
severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) have emerged …
SM Hamed, MM Sakr, GS El-Housseiny, R Wasfi… - Future science …, 2023 - Taylor & Francis
The understanding of any disease calls for studying specific biological structures called
epitopes. One important tool recently drawing attention and improving efficiency in both …

Blockade of TMPRSS2-mediated priming of SARS-CoV-2 by lactoferricin

A Ohradanova-Repic, R Skrabana… - Frontiers in …, 2022 - frontiersin.org
In addition to vaccines, there is an urgent need for supplemental antiviral therapeutics to
dampen the persistent COVID-19 pandemic caused by the severe acute respiratory …

[HTML][HTML] Lactoferrin binds through its N-terminus to the receptor-binding domain of the SARS-coV-2 spike protein

P Babulic, O Cehlar, G Ondrovičová, T Moskalets… - Pharmaceuticals, 2024 - mdpi.com
Lactoferrin Binds through Its N-Terminus to the Receptor-Binding Domain of the SARS-CoV-2
Spike Protein Next Article in Journal Development of a Lateral Flow Assay for the Detection of …

[HTML][HTML] Potential for a plant-made SARS-CoV-2 neutralizing monoclonal antibody as a synergetic cocktail component

C Jugler, H Sun, F Grill, K Kibler, A Esqueda, H Lai… - Vaccines, 2022 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a public health
crisis over the last two years. Monoclonal antibody (mAb)-based therapeutics against the …

Outpatient treatment options to address the SARS-CoV-2 variant Omicron

MW McCarthy - Expert Review of Anti-infective Therapy, 2022 - Taylor & Francis
ABSTRACT Introduction On 26 November 2021, the World Health Organization's Technical
Advisory Group on SARS-CoV-2 Virus Evolution designated PANGO lineage B. 1.1. 529 a …